Trial Information

Summary: Male and Female patients at least 18 years of age with Restless Leg Syndrome symptoms which interfere with sleep.

Study Description
Study of the effectiveness and safety of an investigational drug in patients with Restless Leg Syndrome.

Study Criteria

  • Male and Females at least 18 years of age with Restless Leg Syndrome symptoms which interfere with sleep on 4 or more nights per week for at least 12 weeks
  • Not have any breathing-related sleep disorders or REM sleep behavior disorder
  • Women of child bearing potential must not be pregnant or breast feeding and agree not to become pregnant (on an acceptable method of birth control)

Contact:

David Deshotels, President
Gulf Coast Research Associates, Inc.
2133 Silverside Dr. Ste. D
Baton Rouge, LA 70808
Telephone: 225-757-1084
Fax: 225-757-0294
Email:

Profile Page: Gulf Coast Research Associates, Inc., Baton Rouge, LA

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:40 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA